Member Info for PM2022

Keeping close eye here. Sold some recently as any deal news probably take a bit of time but I do think this will be the next big thing. Nuvec is a very different concept and is very in demand should it work. I have a large holding in VAL and that is due a deal imminently so hopefully i'll be back soon. This stocks reminds a lot of VAL which I was holding for a year as it was dead at mainly 18-22p range but a stage comes where things change. I can see that time coming here at some point soon. Good luck.

Here are my notes for newbies. As always do your own research as well.

Current market cap only 30 million. This is very, very low for a drug company with several clinical assets.

1) Confirmed VAL 201 deal on track to be announced shortly. Upfront payments, massive milestones and royalties. Appears company will be a very large pharmaceutical which will also bring huge confidence.
2) Focus now on VAL 401 to get a deal here soon. Again expect a decent deal here after 201 deal.
3) Val 301 with Japanese for the last 17 months. Inbound queries from many other pharmaceuticals as confirmed in the meeting a few weeks ago. Deal highly likely here as well.
4) Cash spend is amongst the best on AIM for a drugs company. Strategy to out license future drugs means no risk of large placing. No placing planned for some considerable time. Should increase confidence.
5) Confirmed institutional investors are planned with Cenkos on board who will be supporting with this.
6) Lots of projects to be taken that will require low funding to be sold on at pre clinical stage for many millions if they show promise.
7) PYC work is almost complete and would likely have increased the value of our drugs significantly. Also potential findings for other treatments like other cancers or Sepsis.
8) PYC to get 6% of any deal. Cenkos 6% warrants from next year so will want share price to do well. Both on board as strong support.
9) First deal is decades will bring huge confidence here. Key note we only have 65 million shares therefore potential to rise quickly.
10) LIkely 201 will get to market based on lack of side effects, science and success rate so far. Therefore likely to be worth billions.

We have a great CEO and board that cares about the shareholders. No doubt big news will come shortly and the world will be jumping in. Fair price after deal is likely to be £1-£2 pound mark depending on finances and push on from here. I can see Val being many, amny £s in the next year or two with a very large market cap.

I am Keeping those shares because this will very likely be a once in a lifetime investment. The only way is up from this market cap with very, very low risk from here. Remember we are very cheap at the moment at a 30 million market cap and a deal likely to be about to be announced very soon. Strong support at any dips reduces any risk as well so a great investment here and now.

Next leg up to 74 p before deal to test last years high with a huge deal to be announced shortly.

Another big day tomorrow as the volume is picking up. Good luck all.

As I said Mr Long if you want guaranteed then keep a look out for the RNS but you will pay a price a far bigger price than now. Otherwise go and do one and no reason for you to be here.

45 Min left volume should pick up. FOMO kicks in as we are getting very close and one of these mornings we will wake up to a gigantic RNS. It will be a lock out then any huge gap up will be possible.

Feel free to jump in after RNS then Mr Long. We will see you jumping in at 150p, 200p because it will not be easy to buy in and as we have been undervalued by so much we will at a decent price by then.

Good luck an opportunity still remains at this price.

Ignore the naysayers they are just trying to get in cheaper but the reality is we are so undervalued and this is already cheap as chips and a deal can come any day. As good an opportunity as it gets in my opinion.

Looks like someone is desperate to get in DRlong. Do you have any idea of what a standard deal looks like. Our market cap is only 30 million. Here look at one as an example and then tell me how undervalued we really are. Add to that a nice big pharmaceutical and a few more deals.

· AstraZeneca granted exclusive global licence for the development and commercialisation of RXC006, a porcupine inhibitor, for fibrotic diseases

· Redx will receive up to $17 million in early payments between deal signature and the successful commencement of first clinical trial

· Redx will receive up to a further $360 million in development and commercial milestones, plus tiered royalties

· Redx continues to progress its lead oncology asset, RXC004, also a porcupine inhibitor, currently in phase 1/2 clinical trial, and RXC007, the oral Rock 2 inhibitor targeting fibrosis



Alderley Park, 4 August 2020 Redx Pharma plc (AIM: REDX) announces it has signed a significant out licensing agreement for its porcupine inhibitor, RXC006, with AstraZeneca. AstraZeneca will take RXC006 forward into clinical development, targeting fibrotic diseases including idiopathic pulmonary fibrosis (IPF).

It's highly unlikely we will be anywhere near this price after the deal which is almost guaranteed.

Not often we get better opportunities here. Far better than risking elsewhere in my opinion and waiting forever but here we have a great CEO and longer term prospects as well as shorter term.

I would not worry about it. No dilution as it stands and no plans as far as we have all been told.

I think they are filling a large order so we should head back up later on.

They will have to reach equilibrium state before a deal which in my opinion is about 80p and then rise a decent amount after is decent deal otherwise upside will be massive multi bagging if anything near a decent deal is announced.

We are so undervalued at the moment so keep hold and certainly a great buying opportunity when considering risk to reward ratio. Also not to forget 301 and 401 looks like it is making big progress and could also net big deals. 65 Million shares only so will blow if decent deal is announced.

Good buying opportunity. Hard to do a treeshake at this price.

Here are my notes for newbies. As always do your own research as well.

Current market cap only 29 million. This is very, very low for a drug company with several clinical assets.

1) Confirmed VAL 201 deal on track to be announced shortly. Upfront payments, massive milestones and royalties. Appears company will be a very large pharmaceutical which will also bring huge confidence.
2) Focus now on VAL 401 to get a deal here soon. Again expect a decent deal here after 201 deal.
3) Val 301 with Japanese for the last 17 months. Inbound queries from many other pharmaceuticals as confirmed in the meeting a few weeks ago. Deal highly likely here as well.
4) Cash spend is amongst the best on AIM for a drugs company. Strategy to out license future drugs means no risk of large placing. Confirmed no placing planned for some considerable time. Should increase confidence.
5) Confirmed institutional investors are planned with Cenkos on board who will be supporting with this.
6) Lots of projects to be taken that will require low funding to be sold on at pre clinical stage for many millions if they show promise.
7) PYC work is almost complete and would likely have increased the value of our drugs significantly. Also potential findings for other treatments like other cancers or Sepsis.
8) PYC to get 6% of any deal. Cenkos 6% warrants from next year so will want share price to do well. Both on board as strong support.
9) First deal is decades will bring huge confidence here. Key note we only have 65 million shares therefore potential to rise quickly.
10) LIkely 201 will get to market based on lack of side effects, science and success rate so far. Therefore likely to be worth billions.

We have a great CEO and board that cares about the shareholders. No doubt big news will come shortly and the world will be jumping in. Fair price after deal is likely to be £1-£2 pound mark depending on finances and push on from here. I can see Val being many £s in the next year or two with a very large market cap.

I am Keeping those shares because this will very likely be a once in a lifetime investment. The only way is up from this market cap with very, very low risk from here. Remember we are very cheap at the moment at a 26 million market cap and a deal likely to be about to be announced very soon. Strong support at any dips reduces any risk as well so a great investment here and now.

BIg move likely lunchtime. Last years highs could be reached today 70 odd close today I hope. We are so undervalued even before a hint of a deal.

Here are my notes for newbies. As always do your own research as well.

Current market cap only 29 million. This is very, very low for a drug company with several clinical assets.

1) Confirmed VAL 201 deal on track to be announced shortly. Upfront payments, massive milestones and royalties. Appears company will be a very large pharmaceutical which will also bring huge confidence.
2) Focus now on VAL 401 to get a deal here soon. Again expect a decent deal here after 201 deal.
3) Val 301 with Japanese for the last 17 months. Inbound queries from many other pharmaceuticals as confirmed in the meeting a few weeks ago. Deal highly likely here as well.
4) Cash spend is amongst the best on AIM for a drugs company. Strategy to out license future drugs means no risk of large placing. Confirmed no placing planned for some considerable time. Should increase confidence.
5) Confirmed institutional investors are planned with Cenkos on board who will be supporting with this.
6) Lots of projects to be taken that will require low funding to be sold on at pre clinical stage for many millions if they show promise.
7) PYC work is almost complete and would likely have increased the value of our drugs significantly. Also potential findings for other treatments like other cancers or Sepsis.
8) PYC to get 6% of any deal. Cenkos 6% warrants from next year so will want share price to do well. Both on board as strong support.
9) First deal is decades will bring huge confidence here. Key note we only have 65 million shares therefore potential to rise quickly.
10) LIkely 201 will get to market based on lack of side effects, science and success rate so far. Therefore likely to be worth billions.

We have a great CEO and board that cares about the shareholders. No doubt big news will come shortly and the world will be jumping in. Fair price after deal is likely to be £1-£2 pound mark depending on finances and push on from here. I can see Val being many £s in the next year or two with a very large market cap.

I am Keeping those shares because this will very likely be a once in a lifetime investment. The only way is up from this market cap with very, very low risk from here. Remember we are very cheap at the moment at a 26 million market cap and a deal likely to be about to be announced very soon. Strong support at any dips reduces any risk as well so a great investment here and now.

Here is a great post from Porky to be read again for new investors.

Obviously, you can expect nothing less from me than full on, in your face positivity, but by God that Interview was something else, wasn’t it?

Just incredible,

There will be a few miffed individuals that sold stock on Friday thinking they would be able to buy back a bit cheaper and play the waves but that interview firmly kicked that into touch. It will be manic tomorrow with buyers trying to get in.

I would not be surprised if by close Monday we are well into the 50’s if not the 60’s. I think 80p is an absolute given now pre contracts and well north of our first pound on contracts.

It’s now when and not If, Lets face facts here: -

Market Cap at 40p is still ONLY £26m – Crazy, Crazy, Cheap
Market Cap at 55p is just £35m

PEER AVERAGE 80p REPRESENTS £ 52m which was discussed today

Market Cap at £1 = £65m
Market Cap at £2 = £130m

Same business on the NASDAQ was quoted today as being north of £3

What an absolute GEM of an investment this is, it is like shooting fish in a barrel, just can’t go wrong at these levels.

Appreciate we are still miles away for some of the longer term to make a profit but its coming. The re-rate has started, and we are in for one hell of a ride

Strap yourselves in and enjoy… it’s poetry in motion, Only way is up Baby….

Have fun…

Pork’s

Here is a great post from Porky to be read again.

Obviously, you can expect nothing less from me than full on, in your face positivity, but by God that Interview was something else, wasn’t it?

Just incredible,

There will be a few miffed individuals that sold stock on Friday thinking they would be able to buy back a bit cheaper and play the waves but that interview firmly kicked that into touch. It will be manic tomorrow with buyers trying to get in.

I would not be surprised if by close Monday we are well into the 50’s if not the 60’s. I think 80p is an absolute given now pre contracts and well north of our first pound on contracts.

It’s now when and not If, Lets face facts here: -

Market Cap at 40p is still ONLY £26m – Crazy, Crazy, Cheap
Market Cap at 55p is just £35m

PEER AVERAGE 80p REPRESENTS £ 52m which was discussed today

Market Cap at £1 = £65m
Market Cap at £2 = £130m

Same business on the NASDAQ was quoted today as being north of £3

What an absolute GEM of an investment this is, it is like shooting fish in a barrel, just can’t go wrong at these levels.

Appreciate we are still miles away for some of the longer term to make a profit but its coming. The re-rate has started, and we are in for one hell of a ride

Strap yourselves in and enjoy… it’s poetry in motion, Only way is up Baby….

Have fun…

Pork’s

52p is very cheap. 73p target today possibly 80-90p before a deal is a possibility.

201 data was done back in June or before and work was all completed. They are now working on 401.

Nothing outstanding left on 201 and a deal is imminent. Just a signature required at this very low market cap. Looking to buy more early at this cheap market cap.

Baldy,

After this interview it seems like most will end up being longer term holders despite multi bagging from current value when it rises. This is because why invest elsewhere and risk losing money and waiting forever with large placings and all the other crap elsewhere. Here we will have other deals after 201, media interviews by Suzy, royalty payments, a great board, 65 million shares so a potential for a fast rise therefore to me it looks like a stock that can hit many pounds. One can sell at 100p, 150p but then would only end up risking elsewhere if that is the intention. For me I just need one big hit rather than jumping about and I think this is it. Good luck.

Looking forward to a great end to the year which will be transformational as promised.

Unlike other AIM CEO's they are not on high pay. They really look after the finances of the company. We should not question this. Also as I understand it they have been in negotiations and are not able to buy during that period. She has sufficient shares at a very low price.

Best to stop trying to search for any negatives. The naysayers will always be naysayers. Looking forward to a great Monday and will look to add a few first thing.